The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
AODA compliance accessibility disclaimers
-
As we move into 2021 and towards the next AODA compliance deadline, some sponsors/clients may seek to add an accessibility disclaimer to their websites similar to privacy policy and legal. This can be submitted to PAAB as an FYI. Note that the addition of the disclaimer on pre-gate websites should not link back to the corporate site, similar to requirements for privacy policy and legal pre-gate.
